Table 4. Imaging Diagnosis of Probable HCC.
| Diagnostic Criteria for Probable HCC | |
|---|---|
| In nodules ≥ 1 cm that do not meet the major imaging features of HCC, a diagnosis of “probable” HCC can be assigned by applying ancillary imaging features: 1) nodule without APHE: at least one each of the ancillary features of group A and group B; 2) nodule with APHE but without washout appearance: at least one of the ancillary features in group A or B. | |
| These criteria should be applied only to a lesion that does not show either marked T2 hyperintensity or targetoid appearances on diffusion-weighted images or contrast-enhanced images. | |
| Ancillary Imaging Features of HCC | |
| Ancillary features suggesting malignancy in general (group A) | Ancillary features favoring HCC in particular (group B) |
| ·Mild-to-moderate T2 hyperintensity | ·Enhancing or non-enhancing capsule |
| ·High signal intensity on diffusion-weighted imaging | ·Mosaic architecture |
| ·Threshold growth* | ·Nodule-in-nodule |
*Threshold growth is defined as a size growth of the nodule of at least 50% in the longest dimension in ≤ 6 months on computed tomography or magnetic resonance imaging [165]. HCC = hepatocellular carcinoma, APHE = arterial phase hyperenhancement